Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-026146
Filing Date
2025-03-20
Accepted
2025-03-20 16:17:12
Documents
2
Period of Report
2025-03-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm259812-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm259812-1_3seq1.xml 3 1625
2 EXHIBIT 24 tm259812d1_ex24.htm EX-24 12195
  Complete submission text file 0001104659-25-026146.txt   15495
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Issuer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
SIC: 0000

Mailing Address C/O ABRDN 1900 MARKET STREET, SUITE 200 PHILDADELPHIA PA 19103
Business Address
Kim Andrew Wonil (Reporting) CIK: 0001908679 (see all company filings)

Type: 3 | Act: 34 | File No.: 811-06565 | Film No.: 25756664